Yet overall performance was good with both the ESC and High-STEACS strategies, leaving hospitals room to choose.

Sciensus and Rare Patient Voice share new insights that reveal critical opportunity to improve care pathways When nearly half of respondents describe travel as a meaningful burden, it signals a clear ...

"Gene editing takes centre stage in FDA’s new rare disease approval pathway" was originally created and published by ...

The long-term stasis of blood in the liver, known as chronic liver congestion, can lead to a range of diseases, some of which ...

The Food and Drug Administration (FDA) announced a new proposal Monday for flexible drug approval pathway treatments ...

Each year, approximately 36,000 people are diagnosed with the disease in the United States, according to the American Cancer ...

Peds-START (Pediatric Specialized Training and Admission to Residency Track) is one of the only programs of its kind in the country that provides medical students interested in pediatrics early ...

Time to first symptomatic skeletal event, whether including or excluding death, was similar between treatment arms. Most patients did not experience skeletal complications during the follow-up period.

Today, the FDA issued draft guidance outlining a new regulatory pathway intended to help sponsors gain approval for highly ...

Peds-START (Pediatric Specialized Training and Admission to Residency Track) is one of the only programs of its kind in the country that provides medical students interested in pediatrics early ...

Longitudinal PRO modeling, rather than time-to-worsening censoring, indicated maintained HRQOL and pain outcomes with ...

With Patient Zero Requiem in Hitman World of Assassination, you can now pursue The Contagion, a quest where you must ...